
Assay Blocking Blog camp elisa hama antibodies hmgb1 elisa iron assay Isotype Monoclonal p24 elisa Pcr pge2 elisa protein carbonyl assay protein carbonyls Recombinant rna Serum
Monitoring of chronic wasting disease using real-time quaking-induced conversion assay in Japan
Richard
- 0
There was no report on Power losing illness (CWD) instances in Japan to this point; nevertheless, there’s concern in regards to the geographic unfold of CWD. To make clear the CWD standing in Japan, we performed CWD monitoring utilizing real-time quaking-induced conversion (RT-QuIC) assay which might detect the low stage of CWD prions.
A complete of 690 obex samples collected from sika deer and Reeves’s muntjac in Hokkaido and Honshu was examined for CWD prions. No CWD-positive instances have been discovered, suggesting that CWD is nonexistent in Japan. Our outcomes additionally point out that RT-QuIC assay is beneficial for steady monitoring of CWD. Moreover, nucleotide sequence evaluation of the PrP gene revealed sika deer in Japan harbor CWD prone allele.
Fahr’s Syndrome Presenting With Hypocalcemia and Psychotic Options
Fahr’s illness is a uncommon genetic neurodegenerative dysfunction described as “bilateral striopallidodentate calcinosis” (BSPDC). It’s characterised by calcium deposition crossing the blood-brain barrier and calcifying totally different mind areas. Right here, we report a case of a 26-year-old Saudi younger girl, referred to as a case of epilepsy since childhood, a significant depressive dysfunction with psychotic options, and hypocalcemia associated to hypoparathyroidism.
CT mind confirmed intensive coarse calcifications involving the infra and supratentorial white matter, predominantly inside the basal ganglia, thalami, and dentate nuclei of cerebellar hemispheres. This report will talk about the difficult presentation, medical signs, and the multidisciplinary strategy to handle Fahr’s syndrome signs. In conclusion, this case emphasizes the significance of neuroimaging and metabolic workup when investigating the seizure’s etiology. The objective of therapy in Fahr’s syndrome is to handle the underlying situations.
MicroRNA-21: An Rising Participant in Bone Ailments
MicroRNAs (MiRNAs) are small endogenous non-coding RNAs that bind to the three’-untranslated area of goal genes and promote their degradation or inhibit translation, thereby regulating gene expression. MiRNAs are ubiquitous in biology and are concerned in lots of organic processes, enjoying an necessary function in a wide range of physiological and pathological processes.
MiRNA-21 (miR-21) is one in every of them. In recent times, miR-21 has acquired a whole lot of consideration from researchers as an rising participant in orthopedic ailments. MiR-21 is intently related to the incidence, growth, therapy, and prevention of orthopedic ailments via a wide range of mechanisms.
This evaluation summarizes its results on osteoblasts, osteoclasts and their relationship with osteoporosis, fracture, osteoarthritis (OA), osteonecrosis, offering a brand new mind-set for the analysis, therapy and prevention of those bone ailments.
Well being-Associated Stigma, Social Assist, Self-Efficacy, and Self-Care Actions Amongst Adults With Sickle Cell Illness in Oman
Stigma contributes to the burden of people and households affected by Sickle cell illness (SCD) and causes delay in applicable care in search of. The goal of this research is to look at the degrees and associations between stigma, social assist, self-efficacy, and self-care actions amongst grownup sufferers with SCD in Oman utilizing a cross-sectional, correlational design.
Of the 264 individuals, 56.1% (n = 148) have been males, with imply age of 30.1 years (SD 7.7). Half of the individuals have been married, and 88.3% had no different related ailments. The outcomes display that sufferers in Oman endure from health-related stigma.
Nonetheless, social assist, self-efficacy, and self-care actions have been reported to be excessive and correlated with a number of medical and demographic variables. Primarily based on the outcomes, efficient, low-cost interventions similar to psycho-educational teams, particular person counseling, or group therapies may be developed. They’ll promote perception in enhanced efficacy and improved SCD adaptation, thereby growing affected person, and supplier satisfaction.
All illness begins within the intestine’-the function of the intestinal microbiome in ankylosing spondylitis
Ankylosing spondylitis is a persistent, debilitating arthritis with a predilection for the axial skeleton. It has a robust genetic predisposition, however the exact pathogenetic mechanisms concerned in its growth haven’t but been absolutely elucidated.
This has implications each for early analysis and for efficient administration. Just lately, alterations within the intestinal microbiome have been implicated in illness pathogenesis. On this evaluation, we summarize research assessing the intestinal microbiome in AS pathogenesis, along with synthesizing the literature exploring the postulated mechanisms by which it exerts it pathogenic potential. Lastly, we evaluation research analysing manipulation of the microbiome as a possible therapeutic avenue in AS administration.
Immunoregulatory T cell epitope peptides for the therapy of allergic illness
Allergic ailments are kind 2 inflammatory reactions with an growing worldwide prevalence, making the seek for new therapeutic choices pertinent. Allergen immunotherapy is the one disease-modifying strategy for allergic rhinitis, although it may end up in systemic reactions.
Just lately, peptide immunotherapy (PIT), involving T cell epitope peptides that bind to main histocompatibility complexes, have been developed. It’s speculated that they’ll induce T helper cell kind 2 anergy, Treg cell upregulation or immune deviation.
Promising leads to cat dander, honeybee venom, Japanese cedar pollen, grass pollens, ragweed and home mud mite medical trials have proven security, efficacy and tolerability to PIT. Therefore, PIT could maintain the potential to vary the therapy algorithm for allergic rhinitis.
Immunomodulatory Capabilities of TRPM7 and its Implications in Autoimmune Ailments
Autoimamune illness is an inappropriate response to at least one’s tissues as a consequence of a break in immune tolerance and publicity to self-antigens. It typically results in structural and useful injury to organs in addition to systemic problems. Thus far, there aren’t any efficient interventions to forestall the development of autoimmune ailments.
Therefore, there’s an pressing want for brand spanking new therapy targets. TRPM7 is an enzyme-coupled, transient receptor ion channel of the subfamily M that performs a significant function in pathologic and physiologic situations. Whereas TRPM7 is constitutively activated below sure situations, it may well regulate cell migration, polarization, proliferation, and cytokine secretion.
pYLEX1 - Expression Vector |
|||
FYY203-5MG | Yeastern Biotech | 5mg | Ask for price |
Blunt E1 Expression Kit |
|||
abx098098-10rxns | Abbexa | 10 rxns | EUR 560.4 |
Blunt E2 Expression Kit |
|||
abx098873-10rxns | Abbexa | 10 rxns | EUR 560.4 |
RFP expression Adenovirus |
|||
AVP001 | GenTarget | 1x109 IFU/ml x 200ul | EUR 418.8 |
Description: pre-made RFP expression adenovirus, provided in DMEM medium. |
CFP expression Adenovirus |
|||
AVP002 | GenTarget | 1x109 IFU/ml x 200ul | EUR 418.8 |
Description: pre-made CFP expression adenovirus, provided in DMEM medium. |
GFP expression Adenovirus |
|||
AVP011 | GenTarget | 1x109 IFU/ml x 200ul | EUR 418.8 |
Description: pre-made GFP expression adenovirus, provided in DMEM medium. |
YFP expression Adenovirus |
|||
AVP012 | GenTarget | 1x109 IFU/ml x 200ul | EUR 418.8 |
Description: pre-made YFP expression adenovirus, provided in DMEM medium. |
BFP expression Adenovirus |
|||
AVP017 | GenTarget | 1x109 IFU/ml x 200ul | EUR 418.8 |
Description: pre-made BFP expression adenovirus, provided in DMEM medium. |
h OCT4 expression Adenovirus, in vivo ready |
|||
AVP013-PBS | GenTarget | 1x1011 IFU/ml x 50ul | EUR 852 |
Description: pre-made adenovirus express human stem cell factor, OCT4, provided in PBS solution for in vivo application. |
h SOX2 expression Adenovirus, in vivo ready |
|||
AVP014-PBS | GenTarget | 1x1011 IFU/ml x 50ul | EUR 852 |
Description: pre-made adenovirus express human stem cell factor, SOX2, provided in PBS solution for in vivo application. |
h LIN28 expression Adenovirus, in vivo ready |
|||
AVP015-PBS | GenTarget | 1x1011 IFU/ml x 50ul | EUR 852 |
Description: pre-made adenovirus express human stem cell factor, LIN28, provided in PBS solution for in vivo application. |
Rac1 Expression Vector Set |
|||
STA-454 | Cell Biolabs | 1 kit | EUR 1765.2 |
Description: Rac1 Expression Vector Set contains 3 vectors: Rac wild type, T17N dominant negative mutant, and G12V constitutively active mutant. |
RhoA Expression Vector Set |
|||
STA-456 | Cell Biolabs | 1 kit | EUR 1765.2 |
Description: RhoA Expression Vector Set contains 3 vectors: RhoA wild type, T19N dominant negative mutant, and G14V constitutively active mutant. |
Cdc42 Expression Vector Set |
|||
STA-455 | Cell Biolabs | 1 kit | EUR 1765.2 |
Description: Cdc42 Expression Vector Set contains 3 vectors: Cdc42 wild type, T17N dominant negative mutant, and Q61L constitutively active mutant. |
h ADA Expression Lentivirus |
|||
LVP923 | GenTarget | 1x107 IFU/ml x 200ul | EUR 541.2 |
Description: Pre-made over-expression lentivirus for human target: ADA, containing a RFP-Blasticidin dual selection marker. |
h IL6 Expression Lentivirus |
|||
LVP1144 | GenTarget | 1x107 IFU/ml x 200ul | EUR 541.2 |
Description: Pre-made over-expression lentivirus for human target: HDAC1, containing a RFP-Blasticidin dual selection marker. |
h CD4 Expression Lentivirus |
|||
LVP1152 | GenTarget | 1x107 IFU/ml x 200ul | EUR 541.2 |
Description: Pre-made over-expression lentivirus for human target: CD4, containing a RFP-Blasticidin dual selection marker. |
h IL4 Expression Lentivirus |
|||
LVP1161 | GenTarget | 1x107 IFU/ml x 200ul | EUR 541.2 |
Description: Pre-made over-expression lentivirus for human target: IL4, containing a RFP-Blasticidin dual selection marker. |
h IL7 Expression Lentivirus |
|||
LVP1162 | GenTarget | 1x107 IFU/ml x 200ul | EUR 541.2 |
Description: Pre-made over-expression lentivirus for human target: IL7, containing a RFP-Blasticidin dual selection marker. |
h KDR Expression Lentivirus |
|||
LVP1176 | GenTarget | 1x107 IFU/ml x 200ul | EUR 541.2 |
Description: Pre-made over-expression lentivirus for human target: KDR, containing a RFP-Blasticidin dual selection marker. |
h FAS Expression Lentivirus |
|||
LVP1181 | GenTarget | 1x107 IFU/ml x 200ul | EUR 541.2 |
Description: Pre-made over-expression lentivirus for human target: FAS, containing a RFP-Blasticidin dual selection marker. |
pAAV-MCS Expression Vector |
|||
VPK-410 | Cell Biolabs | 10 µg | EUR 776.4 |
Description: Clone your gene of interest into this AAV Expression Vector, then co-transfect along with AAV packaging vectors into a packaging host cell line such as 293AAV. |
h OCT4 expression Adenovirus |
|||
AVP013 | GenTarget | 1x109 IFU/ml x 200ul | EUR 418.8 |
Description: pre-made adenovirus express human stem cell factor, OCT4, provided in DMEM medium. |
h SOX2 expression Adenovirus |
|||
AVP014 | GenTarget | 1x109 IFU/ml x 50ul | EUR 418.8 |
Description: pre-made adenovirus express human stem cell factor, SOX2, provided in DMEM medium. |
h CDR1 Expression Lentivirus |
|||
LVP917 | GenTarget | 1x107 IFU/ml x 200ul | EUR 541.2 |
Description: Pre-made over-expression lentivirus for human target: CDR1, containing a RFP-Blasticidin dual selection marker. |
h CD47 Expression Lentivirus |
|||
LVP918 | GenTarget | 1x107 IFU/ml x 200ul | EUR 541.2 |
Description: Pre-made over-expression lentivirus for human target: CD47, containing a RFP-Blasticidin dual selection marker. |
h ESR1 Expression Lentivirus |
|||
LVP924 | GenTarget | 1x107 IFU/ml x 200ul | EUR 541.2 |
Description: Pre-made over-expression lentivirus for human target: ESR1, containing a RFP-Blasticidin dual selection marker. |
r Syn1 Expression Lentivirus |
|||
LVP925 | GenTarget | 1x107 IFU/ml x 200ul | EUR 541.2 |
Description: Pre-made over-expression lentivirus for rat target: Syn1, containing a RFP-Blasticidin dual selection marker. |
h NME4 Expression Lentivirus |
|||
LVP932 | GenTarget | 1x107 IFU/ml x 200ul | EUR 541.2 |
Description: Pre-made over-expression lentivirus for human target: NME4, containing a RFP-Blasticidin dual selection marker. |
h EGFR Expression Lentivirus |
|||
LVP1142 | GenTarget | 1x107 IFU/ml x 200ul | EUR 541.2 |
Description: Pre-made over-expression lentivirus for human target: EGFR, containing a RFP-Blasticidin dual selection marker. |
h NRP1 Expression Lentivirus |
|||
LVP1145 | GenTarget | 1x107 IFU/ml x 200ul | EUR 541.2 |
Description: Pre-made over-expression lentivirus for human target: HDAC1, containing a RFP-Blasticidin dual selection marker. |
h MUC1 Expression Lentivirus |
|||
LVP1148 | GenTarget | 1x107 IFU/ml x 200ul | EUR 541.2 |
Description: Pre-made over-expression lentivirus for human target: HDAC1, containing a RFP-Blasticidin dual selection marker. |
h CD8a Expression Lentivirus |
|||
LVP1151 | GenTarget | 1x107 IFU/ml x 200ul | EUR 541.2 |
Description: Pre-made over-expression lentivirus for human target: CD8a, containing a RFP-Blasticidin dual selection marker. |
h PIGF Expression Lentivirus |
|||
LVP1154 | GenTarget | 1x107 IFU/ml x 200ul | EUR 541.2 |
Description: Pre-made over-expression lentivirus for human target: PIGF, containing a RFP-Blasticidin dual selection marker. |
h BRAF Expression Lentivirus |
|||
LVP1156 | GenTarget | 1x107 IFU/ml x 200ul | EUR 541.2 |
Description: Pre-made over-expression lentivirus for human target: BRAF, containing a RFP-Blasticidin dual selection marker. |
h ROS1 Expression Lentivirus |
|||
LVP1158 | GenTarget | 1x107 IFU/ml x 200ul | EUR 541.2 |
Description: Pre-made over-expression lentivirus for human target: ROS1, containing a RFP-Blasticidin dual selection marker. |
h CD3E Expression Lentivirus |
|||
LVP1163 | GenTarget | 1x107 IFU/ml x 200ul | EUR 541.2 |
Description: Pre-made over-expression lentivirus for human target: IL7, containing a RFP-Blasticidin dual selection marker. |
h KLK3 Expression Lentivirus |
|||
LVP1171 | GenTarget | 1x107 IFU/ml x 200ul | EUR 541.2 |
Description: Pre-made over-expression lentivirus for human target: KLK3, containing a RFP-Blasticidin dual selection marker. |
h NEK6 Expression Lentivirus |
|||
LVP1182 | GenTarget | 1x107 IFU/ml x 200ul | EUR 541.2 |
Description: Pre-made over-expression lentivirus for human target: NEK6, containing a RFP-Blasticidin dual selection marker. |
h NEK7 Expression Lentivirus |
|||
LVP1183 | GenTarget | 1x107 IFU/ml x 200ul | EUR 541.2 |
Description: Pre-made over-expression lentivirus for human target: NEK7, containing a RFP-Blasticidin dual selection marker. |
h LIN28 expression Adenovirus |
|||
AVP015 | GenTarget | 1x109 IFU/ml x 200ul | EUR 418.8 |
Description: pre-made adenovirus express human stem cell factor, LIN28, provided in DMEM medium. |
h GPNMB Expression Lentivirus |
|||
LVP921 | GenTarget | 1x107 IFU/ml x 200ul | EUR 541.2 |
Description: Pre-made over-expression lentivirus for human target: GPNMB, containing a RFP-Blasticidin dual selection marker. |
h DECR1 Expression Lentivirus |
|||
LVP927 | GenTarget | 1x107 IFU/ml x 200ul | EUR 541.2 |
Description: Pre-made over-expression lentivirus for human target: DECR1, containing a RFP-Blasticidin dual selection marker. |
h DECR2 Expression Lentivirus |
|||
LVP928 | GenTarget | 1x107 IFU/ml x 200ul | EUR 541.2 |
Description: Pre-made over-expression lentivirus for human target: DECR2, containing a RFP-Blasticidin dual selection marker. |
h NMRK1 Expression Lentivirus |
|||
LVP930 | GenTarget | 1x107 IFU/ml x 200ul | EUR 541.2 |
Description: Pre-made over-expression lentivirus for human target: NMRK1, containing a RFP-Blasticidin dual selection marker. |
h PITX3 Expression Lentivirus |
|||
LVP931 | GenTarget | 1x107 IFU/ml x 200ul | EUR 541.2 |
Description: Pre-made over-expression lentivirus for human target: PITX3, containing a RFP-Blasticidin dual selection marker. |
h HDAC1 Expression Lentivirus |
|||
LVP1143 | GenTarget | 1x107 IFU/ml x 200ul | EUR 541.2 |
Description: Pre-made over-expression lentivirus for human target: HDAC1, containing a RFP-Blasticidin dual selection marker. |
h VEGFB Expression Lentivirus |
|||
LVP1146 | GenTarget | 1x107 IFU/ml x 200ul | EUR 541.2 |
Description: Pre-made over-expression lentivirus for human target: HDAC1, containing a RFP-Blasticidin dual selection marker. |
h PARP1 Expression Lentivirus |
|||
LVP1149 | GenTarget | 1x107 IFU/ml x 200ul | EUR 541.2 |
Description: Pre-made over-expression lentivirus for human target: HDAC1, containing a RFP-Blasticidin dual selection marker. |
h IL3RA Expression Lentivirus |
|||
LVP1150 | GenTarget | 1x107 IFU/ml x 200ul | EUR 541.2 |
Description: Pre-made over-expression lentivirus for human target: IL3RA, containing a RFP-Blasticidin dual selection marker. |
h PTCH1 Expression Lentivirus |
|||
LVP1155 | GenTarget | 1x107 IFU/ml x 200ul | EUR 541.2 |
Description: Pre-made over-expression lentivirus for human target: PTCH1, containing a RFP-Blasticidin dual selection marker. |
h SART3 Expression Lentivirus |
|||
LVP1159 | GenTarget | 1x107 IFU/ml x 200ul | EUR 541.2 |
Description: Pre-made over-expression lentivirus for human target: SART3, containing a RFP-Blasticidin dual selection marker. |
h TIGIT Expression Lentivirus |
|||
LVP1160 | GenTarget | 1x107 IFU/ml x 200ul | EUR 541.2 |
Description: Pre-made over-expression lentivirus for human target: TIGIT, containing a RFP-Blasticidin dual selection marker. |
h EDNRA Expression Lentivirus |
|||
LVP1165 | GenTarget | 1x107 IFU/ml x 200ul | EUR 541.2 |
Description: Pre-made over-expression lentivirus for human target: EDNRA containing a RFP-Blasticidin dual selection marker. |
h Foxp3 Expression Lentivirus |
|||
LVP1172 | GenTarget | 1x107 IFU/ml x 200ul | EUR 541.2 |
Description: Pre-made over-expression lentivirus for human target: Foxp3, containing a RFP-Blasticidin dual selection marker. |
m RIKEN Expression Lentivirus |
|||
LVP1174 | GenTarget | 1x107 IFU/ml x 200ul | EUR 541.2 |
Description: Pre-made over-expression lentivirus for mouse target: RIKEN, containing a RFP-Blasticidin dual selection marker. |
h APLP2 Expression Lentivirus |
|||
LVP1177 | GenTarget | 1x107 IFU/ml x 200ul | EUR 541.2 |
Description: Pre-made over-expression lentivirus for human target: APLP2, containing a RFP-Blasticidin dual selection marker. |
h PCSK9 Expression Lentivirus |
|||
LVP1178 | GenTarget | 1x107 IFU/ml x 200ul | EUR 541.2 |
Description: Pre-made over-expression lentivirus for human target: PCSK9, containing a RFP-Blasticidin dual selection marker. |
h NTSR1 Expression Lentivirus |
|||
LVP1179 | GenTarget | 1x107 IFU/ml x 200ul | EUR 541.2 |
Description: Pre-made over-expression lentivirus for human target: NTSR1, containing a RFP-Blasticidin dual selection marker. |
pscAAV-MCS Expression Vector |
|||
VPK-430 | Cell Biolabs | 10 µg | EUR 776.4 |
Description: Clone your gene of interest into this AAV Expression Vector, then co-transfect along with AAV packaging vectors into a packaging host cell line such as 293AAV. |
H-Ras Expression Vector Set |
|||
STA-457 | Cell Biolabs | 1 kit | EUR 1765.2 |
Description: H-Ras Expression Vector Set contains 3 vectors: H-Ras wild type, T19N dominant negative mutant, and G12V constitutively active mutant. |
m CTAGA1 Expression Lentivirus |
|||
LVP916 | GenTarget | 1x107 IFU/ml x 200ul | EUR 541.2 |
Description: Pre-made over-expression lentivirus for mouse target: CTAGA1, containing a RFP-Blasticidin dual selection marker. |
h SKIV2L Expression Lentivirus |
|||
LVP919 | GenTarget | 1x107 IFU/ml x 200ul | EUR 541.2 |
Description: Pre-made over-expression lentivirus for human target: SKIV2L, containing a RFP-Blasticidin dual selection marker. |
h SKIV2L Expression Lentivirus |
|||
LVP919-GP | GenTarget | 1x107 IFU/ml x 200ul | EUR 541.2 |
Description: Pre-made over-expression lentivirus for human target: SKIV2L, containing a GFP-Puromycin dual selection marker. |
h TP5313 Expression Lentivirus |
|||
LVP926 | GenTarget | 1x107 IFU/ml x 200ul | EUR 541.2 |
Description: Pre-made over-expression lentivirus for human target: TP5313, containing a RFP-Blasticidin dual selection marker. |
h ELOVL5 Expression Lentivirus |
|||
LVP929 | GenTarget | 1x107 IFU/ml x 200ul | EUR 541.2 |
Description: Pre-made over-expression lentivirus for human target: ELOVL5, containing a RFP-Blasticidin dual selection marker. |
h MAGEA3 Expression Lentivirus |
|||
LVP1147 | GenTarget | 1x107 IFU/ml x 200ul | EUR 541.2 |
Description: Pre-made over-expression lentivirus for human target: HDAC1, containing a RFP-Blasticidin dual selection marker. |
h NANOS3 Expression Lentivirus |
|||
LVP1164 | GenTarget | 1x107 IFU/ml x 200ul | EUR 541.2 |
Description: Pre-made over-expression lentivirus for human target: NANOS3, containing a RFP-Blasticidin dual selection marker. |
h IL1RL1 Expression Lentivirus |
|||
LVP1168 | GenTarget | 1x107 IFU/ml x 200ul | EUR 541.2 |
Description: Pre-made over-expression lentivirus for human target: IL1RL1, containing a RFP-Blasticidin dual selection marker. |
h CTAG1B Expression Lentivirus |
|||
LVP1169 | GenTarget | 1x107 IFU/ml x 200ul | EUR 541.2 |
Description: Pre-made over-expression lentivirus for human target: CTAG1B, containing a RFP-Blasticidin dual selection marker. |
h MAGEA3 Expression Lentivirus |
|||
LVP1170 | GenTarget | 1x107 IFU/ml x 200ul | EUR 541.2 |
Description: Pre-made over-expression lentivirus for human target: MAGEA3, containing a RFP-Blasticidin dual selection marker. |
h COX7A1 Expression Lentivirus |
|||
LVP1173 | GenTarget | 1x107 IFU/ml x 200ul | EUR 541.2 |
Description: Pre-made over-expression lentivirus for human target: COX7A1, containing a RFP-Blasticidin dual selection marker. |
h BCL11B Expression Lentivirus |
|||
LVP1180 | GenTarget | 1x107 IFU/ml x 200ul | EUR 541.2 |
Description: Pre-made over-expression lentivirus for human target: BCL11B, containing a RFP-Blasticidin dual selection marker. |
pUC57-sgRNA expression vector |
|||
PVT18003 | Lifescience Market | 2 ug | EUR 309.6 |
BRAF, His-Tag (High Expression) |
|||
41237 | BPS Bioscience | 10 µg | EUR 375 |
Description: Human BRAF, also known as B-RAF1 and RAFB1, with 18 mutations to improve expression; S446A, S447A, I543A, I544S, I551K, Q562R, L588N, K630S, F667E, Y672S, A688R, L706S, Q709R, S713E, L716E, S720E, P722S, K723G. GenBank Accession #NM_004333, a.a. 444-723 with N-terminal His-tag, expressed in E. coli cells. MW = 33 kDa. |
ANPRA/Aequorin Expression vector |
|||
60641 | BPS Bioscience | 20 µg | EUR 900 |
Description: The ANPRA/Aequorin expression vector is designed to co-express human atrial natriuretic peptide receptor A (ANPRA, also called natriuretic peptide receptor A/guanylate cyclase A) and jellyfish (Aequorea victoria) Aequorin in mammalian cells. |
h CEACAM5 Expression Lentivirus |
|||
LVP1153 | GenTarget | 1x107 IFU/ml x 200ul | EUR 541.2 |
Description: Pre-made over-expression lentivirus for human target: CEACAM5, containing a RFP-Blasticidin dual selection marker. |
h TNFSF11 Expression Lentivirus |
|||
LVP1157 | GenTarget | 1x107 IFU/ml x 200ul | EUR 541.2 |
Description: Pre-made over-expression lentivirus for human target: TNFSF11, containing a RFP-Blasticidin dual selection marker. |
h TNFRSF1B Expression Lentivirus |
|||
LVP922 | GenTarget | 1x107 IFU/ml x 200ul | EUR 541.2 |
Description: Pre-made over-expression lentivirus for human target: TNFRSF1B, containing a RFP-Blasticidin dual selection marker. |
h KIAA1324 Expression Lentivirus |
|||
LVP1175 | GenTarget | 1x107 IFU/ml x 200ul | EUR 541.2 |
Description: Pre-made over-expression lentivirus for human target: KIAA1324, containing a RFP-Blasticidin dual selection marker. |
GFP-Rac1 Expression Vector Set |
|||
STA-450 | Cell Biolabs | 1 kit | EUR 1939.2 |
Description: GFP-Rac1 Expression Vector Set contains 3 vectors: Rac wild type, T17N dominant negative mutant, and Q61L constitutively active mutant. Each vector also contains a GFP reporter sequence. |
GFP-RhoA Expression Vector Set |
|||
STA-452 | Cell Biolabs | 1 kit | EUR 1939.2 |
Description: GFP-RhoA Expression Vector Set contains 3 vectors: RhoA wild type, T19N dominant negative mutant, and Q63L constitutively active mutant. Each vector also contains a GFP reporter sequence. |
h KIAA0319L Expression Lentivirus |
|||
LVP920 | GenTarget | 1x107 IFU/ml x 200ul | EUR 541.2 |
Description: Pre-made over-expression lentivirus for human target: KIAA0319L, containing a RFP-Blasticidin dual selection marker. |
GFP-Cdc42 Expression Vector Set |
|||
STA-451 | Cell Biolabs | 1 kit | EUR 1939.2 |
Description: GFP-Cdc42 Expression Vector Set contains 3 vectors: Cdc42 wild type, T17N dominant negative mutant, and Q61L constitutively active mutant. Each vector also contains a GFP reporter sequence. |
Active Rac1 Expression Vector Set |
|||
STA-458 | Cell Biolabs | 1 kit | EUR 1765.2 |
Description: Active Rac1 Expression Vector Set contains 3 vectors expressing different constitutively active mutants of Rac1: Q61L, Q61L/F37A, and Q61L/Y40C. |
PhiC31 Integrase Expression Plasmid |
|||
FC200PA-1 | SBI | 10ug | EUR 496 |
pCMV-GFP-LC3 Expression Vector |
|||
CBA-401 | Cell Biolabs | 100 µL | EUR 1243.2 |
Description: Expression vector contains a fusion of GFP and LC3. A separate GFP control vector is also included. |
h KRAS (G12D) Expression Lentivirus |
|||
LVP1166 | GenTarget | 1x107 IFU/ml x 200ul | EUR 541.2 |
Description: Pre-made over-expression lentivirus for a mutant (G12D) of human target: KRAS containing a RFP-Blasticidin dual selection marker. |
Tet-on circRNA Expression Vector |
|||
PVT14643 | Lifescience Market | 2 ug | EUR 843.6 |
h TP53 (R175H) Expression Lentivirus |
|||
LVP1167 | GenTarget | 1x107 IFU/ml x 200ul | EUR 541.2 |
Description: Pre-made over-expression lentivirus for a mutant R175H) of human target: TP53, containing a RFP-Blasticidin dual selection marker. |
pAAV-IRES-Neo Expression Vector |
|||
VPK-416 | Cell Biolabs | 10 µg | EUR 776.4 |
Description: Clone your gene of interest into this AAV Expression Vector, then co-transfect along with AAV packaging vectors into a packaging host cell line such as 293AAV. |
pAAV-IRES-GFP Expression Vector |
|||
VPK-418 | Cell Biolabs | 10 µg | EUR 776.4 |
Description: Clone your gene of interest into this AAV Expression Vector, then co-transfect along with AAV packaging vectors into a packaging host cell line such as 293AAV. |
pAAV-IRES-Bsd Expression Vector |
|||
VPK-419 | Cell Biolabs | 10 µg | EUR 776.4 |
Description: Clone your gene of interest into this AAV Expression Vector, then co-transfect along with AAV packaging vectors into a packaging host cell line such as 293AAV. |
PinPoint Integrase Expression Plasmid |
|||
PIN200A-1 | SBI | 10ug | EUR 688 |
pAAV-IRES-Puro Expression Vector |
|||
VPK-415 | Cell Biolabs | 10 µg | EUR 776.4 |
Description: Clone your gene of interest into this AAV Expression Vector, then co-transfect along with AAV packaging vectors into a packaging host cell line such as 293AAV. |
CEACAM5 CHO Cell Line (Low Expression) |
|||
78704-L | BPS Bioscience | 2 vials | EUR 7150 |
Description: Recombinant clonal CHO cell line stably expressing full-length human CEACAM5 (NM_004363). Surface expression of CEACAM5 was confirmed by flow cytometry. The stable clonal cell line was selected for different levels of CEACAM5 expression (High, Medium, and Low) compared to the parental CHO-K1 cell line. |
Active H-Ras Expression Vector Set |
|||
STA-459 | Cell Biolabs | 1 kit | EUR 1765.2 |
Description: Active H-Ras Expression Vector Set contains 3 vectors expressing different constitutively active mutants of H-Ras: V12, V12S35, and V12C40. |
B7-H3 CHO Cell Line (Low Expression) |
|||
78541-L | BPS Bioscience | 2 vials | EUR 7150 |
Description: B7 homolog 3 protein (B7-H3) CHO Cell line is a recombinant clonal stable CHO cell line expressing full length human B7-H3 protein, also known as cluster of differentiation 276 (CD276, B7H3; B7RP-2; 4Ig-B7-H3). Surface expression of B7-H3 was confirmed by flow cytometry. Each stable clonal cell line was selected for High, Medium, or Low levels of B7-H3 expression to mimic different B7-H3 expression levels in various cancer types. |
pAAV-IRES-Hygro Expression Vector |
|||
VPK-417 | Cell Biolabs | 10 µg | EUR 776.4 |
Description: Clone your gene of interest into this AAV Expression Vector, then co-transfect along with AAV packaging vectors into a packaging host cell line such as 293AAV. |
CD36 HEK293 Cell Line (High Expression) |
|||
78526-H | BPS Bioscience | 2 vials | EUR 7150 |
Description: Recombinant clonal HEK293 cell line stably expressing full length human CD36. The stable clonal cell line was selected for medium and high levels of CD36 expression compared to the parental HEK293 cell line. |
CEACAM5 CHO Cell Line (High Expression) |
|||
78704-H | BPS Bioscience | 2 vials | EUR 7150 |
Description: Recombinant clonal CHO cell line stably expressing full-length human CEACAM5 (NM_004363). Surface expression of CEACAM5 was confirmed by flow cytometry. The stable clonal cell line was selected for different levels of CEACAM5 expression (High, Medium, and Low) compared to the parental CHO-K1 cell line. |
AAV-1 Helper Free Expression System |
|||
VPK-410-SER1 | Cell Biolabs | 1 kit | EUR 1486.8 |
Description: The AAV Helper Free System produces recombinant AAV containing your gene of interest without the need to use a helper adenovirus. The adenoviral genes required for proper AAV packaging are provided in the pHelper plasmid (E2A, E4 and VA RNA) or in the 293 packaging cells (E1). |
AAV-2 Helper Free Expression System |
|||
VPK-410-SER2 | Cell Biolabs | 1 kit | EUR 1486.8 |
Description: The AAV Helper Free System produces recombinant AAV containing your gene of interest without the need to use a helper adenovirus. The adenoviral genes required for proper AAV packaging are provided in the pHelper plasmid (E2A, E4 and VA RNA) or in the 293 packaging cells (E1). |
AAV-3 Helper Free Expression System |
|||
VPK-410-SER3 | Cell Biolabs | 1 kit | EUR 1486.8 |
Description: The AAV Helper Free System produces recombinant AAV containing your gene of interest without the need to use a helper adenovirus. The adenoviral genes required for proper AAV packaging are provided in the pHelper plasmid (E2A, E4 and VA RNA) or in the 293 packaging cells (E1). |
AAV-4 Helper Free Expression System |
|||
VPK-410-SER4 | Cell Biolabs | 1 kit | EUR 1486.8 |
Description: The AAV Helper Free System produces recombinant AAV containing your gene of interest without the need to use a helper adenovirus. The adenoviral genes required for proper AAV packaging are provided in the pHelper plasmid (E2A, E4 and VA RNA) or in the 293 packaging cells (E1). |
AAV-5 Helper Free Expression System |
|||
VPK-410-SER5 | Cell Biolabs | 1 kit | EUR 1486.8 |
Description: The AAV Helper Free System produces recombinant AAV containing your gene of interest without the need to use a helper adenovirus. The adenoviral genes required for proper AAV packaging are provided in the pHelper plasmid (E2A, E4 and VA RNA) or in the 293 packaging cells (E1). |
AAV-6 Helper Free Expression System |
|||
VPK-410-SER6 | Cell Biolabs | 1 kit | EUR 1486.8 |
Description: The AAV Helper Free System produces recombinant AAV containing your gene of interest without the need to use a helper adenovirus. The adenoviral genes required for proper AAV packaging are provided in the pHelper plasmid (E2A, E4 and VA RNA) or in the 293 packaging cells (E1). |
B7-H3 CHO Cell Line (High Expression) |
|||
78541-H | BPS Bioscience | 2 vials | EUR 7150 |
Description: B7 homolog 3 protein (B7-H3) CHO Cell line is a recombinant clonal stable CHO cell line expressing full length human B7-H3 protein, also known as cluster of differentiation 276 (CD276, B7H3; B7RP-2; 4Ig-B7-H3). Surface expression of B7-H3 was confirmed by flow cytometry. Each stable clonal cell line was selected for High, Medium, or Low levels of B7-H3 expression to mimic different B7-H3 expression levels in various cancer types. |
AAV-DJ Helper Free Expression System |
|||
VPK-410-DJ | Cell Biolabs | 1 kit | EUR 1486.8 |
Description: The AAV Helper Free System produces recombinant AAV containing your gene of interest without the need to use a helper adenovirus. The adenoviral genes required for proper AAV packaging are provided in the pHelper plasmid (E2A, E4 and VA RNA) or in the 293 packaging cells (E1). AAV Helper Free Complete Expression Systems are available for native serotypes 1 through 6, as well as the novel AAV-DJ and AAV-DJ/8. The AAV-DJ system provides a hybrid capsid created by DNA shuffling technology combining 8 different native serotypes: AAV-2, AAV-4, AAV-5, AAV-8, AAV-9, avian AAV, bovine AAV, and caprine AAV. The result is a highly infectious vector that can transduce a wide variety of cells and tissues at significantly higher rates than AAV-2. |
Gryphon Retroviral Expression System I |
|||
ABP-RVK-10001 | Allele Biotech | 1 set | Ask for price |
Description: PRODUCT LINE DISCONTINUED. Please contact us. |
Gryphon Retroviral Expression System II |
|||
ABP-RVK-10002 | Allele Biotech | 1 set | Ask for price |
Description: PRODUCT LINE DISCONTINUED. Please contact us. |
CD7 CHO Cell Line (Medium or High Expression)-78324-H |
|||
78324-H | BPS Bioscience | 2 vials | EUR 7150 |
Description: Recombinant CD7 CHO-K1 cell lines expressing full-length human CD7 receptor (accession number: NM_006137.6). Surface expression of human CD7 was confirmed by flow cytometry. Each stable clonal cell line was selected for high or medium levels of CD7 expression to mimic different stages of cancer target cells with various CD7 expression levels. |
CD7 CHO Cell Line (Medium or High Expression)-78324-M |
|||
78324-M | BPS Bioscience | 2 vials | EUR 7150 |
Description: Recombinant CD7 CHO-K1 cell lines expressing full-length human CD7 receptor (accession number: NM_006137.6). Surface expression of human CD7 was confirmed by flow cytometry. Each stable clonal cell line was selected for high or medium levels of CD7 expression to mimic different stages of cancer target cells with various CD7 expression levels. |
CD36 HEK293 Cell Line (Medium Expression) |
|||
78526-M | BPS Bioscience | 2 vials | EUR 7150 |
Description: Recombinant clonal HEK293 cell line stably expressing full length human CD36. The stable clonal cell line was selected for medium and high levels of CD36 expression compared to the parental HEK293 cell line. |
CEACAM5 CHO Cell Line (Medium Expression) |
|||
78704-M | BPS Bioscience | 2 vials | EUR 7150 |
Description: Recombinant clonal CHO cell line stably expressing full-length human CEACAM5 (NM_004363). Surface expression of CEACAM5 was confirmed by flow cytometry. The stable clonal cell line was selected for different levels of CEACAM5 expression (High, Medium, and Low) compared to the parental CHO-K1 cell line. |
Human Myelin expression factor 2 (MYEF2) |
|||
1-CSB-EP015283HU | Cusabio |
|
|
Description: Recombinant Human Myelin expression factor 2(MYEF2),partial expressed in E.coli |
scAAV-1 Helper Free Expression System |
|||
VPK-430-SER1 | Cell Biolabs | 1 kit | EUR 1486.8 |
Description: The AAV Helper Free System produces recombinant AAV containing your gene of interest without the need to use a helper adenovirus. The adenoviral genes required for proper AAV packaging are provided in the pHelper plasmid (E2A, E4 and VA RNA) or in the 293 packaging cells (E1). |
scAAV-2 Helper Free Expression System |
|||
VPK-430-SER2 | Cell Biolabs | 1 kit | EUR 1486.8 |
Description: The AAV Helper Free System produces recombinant AAV containing your gene of interest without the need to use a helper adenovirus. The adenoviral genes required for proper AAV packaging are provided in the pHelper plasmid (E2A, E4 and VA RNA) or in the 293 packaging cells (E1). |
scAAV-3 Helper Free Expression System |
|||
VPK-430-SER3 | Cell Biolabs | 1 kit | EUR 1486.8 |
Description: The AAV Helper Free System produces recombinant AAV containing your gene of interest without the need to use a helper adenovirus. The adenoviral genes required for proper AAV packaging are provided in the pHelper plasmid (E2A, E4 and VA RNA) or in the 293 packaging cells (E1). |
scAAV-4 Helper Free Expression System |
|||
VPK-430-SER4 | Cell Biolabs | 1 kit | EUR 1486.8 |
Description: The AAV Helper Free System produces recombinant AAV containing your gene of interest without the need to use a helper adenovirus. The adenoviral genes required for proper AAV packaging are provided in the pHelper plasmid (E2A, E4 and VA RNA) or in the 293 packaging cells (E1). |
scAAV-5 Helper Free Expression System |
|||
VPK-430-SER5 | Cell Biolabs | 1 kit | EUR 1486.8 |
Description: The AAV Helper Free System produces recombinant AAV containing your gene of interest without the need to use a helper adenovirus. The adenoviral genes required for proper AAV packaging are provided in the pHelper plasmid (E2A, E4 and VA RNA) or in the 293 packaging cells (E1). |
scAAV-6 Helper Free Expression System |
|||
VPK-430-SER6 | Cell Biolabs | 1 kit | EUR 1486.8 |
Description: The AAV Helper Free System produces recombinant AAV containing your gene of interest without the need to use a helper adenovirus. The adenoviral genes required for proper AAV packaging are provided in the pHelper plasmid (E2A, E4 and VA RNA) or in the 293 packaging cells (E1). |
B7-H3 CHO Cell Line (Medium Expression) |
|||
78541-M | BPS Bioscience | 2 vials | EUR 7150 |
Description: B7 homolog 3 protein (B7-H3) CHO Cell line is a recombinant clonal stable CHO cell line expressing full length human B7-H3 protein, also known as cluster of differentiation 276 (CD276, B7H3; B7RP-2; 4Ig-B7-H3). Surface expression of B7-H3 was confirmed by flow cytometry. Each stable clonal cell line was selected for High, Medium, or Low levels of B7-H3 expression to mimic different B7-H3 expression levels in various cancer types. |
CD95 CHO Cell Line (Medium or High Expression)-78499-H |
|||
78499-H | BPS Bioscience | 2 vials | EUR 7150 |
Description: The CD95 CHO cell line is a recombinant clonal stable CHO cell line constitutively expressing full-length human CD95 receptor (accession number: NM_000043.3). Surface expression of human CD95 was confirmed by flow cytometry. Each clonal cell line was selected for different levels of CD95 expression (High or Medium) to mimic varying CD95 expression levels in cancer cells. |
CD95 CHO Cell Line (Medium or High Expression)-78499-M |
|||
78499-M | BPS Bioscience | 2 vials | EUR 7150 |
Description: The CD95 CHO cell line is a recombinant clonal stable CHO cell line constitutively expressing full-length human CD95 receptor (accession number: NM_000043.3). Surface expression of human CD95 was confirmed by flow cytometry. Each clonal cell line was selected for different levels of CD95 expression (High or Medium) to mimic varying CD95 expression levels in cancer cells. |
Protein Limb Expression 1 (LIX1) Antibody |
|||
20-abx318393 | Abbexa |
|
|
Protein Limb Expression 1 (LIX1) Antibody |
|||
abx146234-100ug | Abbexa | 100 ug | EUR 469.2 |
Protein Limb Expression 1 (LIX1) Antibody |
|||
abx025913-400ul | Abbexa | 400 ul | EUR 627.6 |
Protein Limb Expression 1 (LIX1) Antibody |
|||
abx025913-80l | Abbexa | 80 µl | EUR 343.2 |
scAAV-DJ Helper Free Expression System |
|||
VPK-430-DJ | Cell Biolabs | 1 kit | EUR 1486.8 |
Description: The AAV Helper Free System produces recombinant AAV containing your gene of interest without the need to use a helper adenovirus. The adenoviral genes required for proper AAV packaging are provided in the pHelper plasmid (E2A, E4 and VA RNA) or in the 293 packaging cells (E1). AAV Helper Free Complete Expression Systems are available for native serotypes 1 through 6, as well as the novel AAV-DJ and AAV-DJ/8. The AAV-DJ system provides a hybrid capsid created by DNA shuffling technology combining 8 different native serotypes: AAV-2, AAV-4, AAV-5, AAV-8, AAV-9, avian AAV, bovine AAV, and caprine AAV. The result is a highly infectious vector that can transduce a wide variety of cells and tissues at significantly higher rates than AAV-2. |
pRedPuro shRNA expression lentivector (EF1) |
|||
SI516A-1 | SBI | 10 ug | EUR 594 |
pAAV-MCS Promoterless Expression Vector |
|||
VPK-411 | Cell Biolabs | 10 µg | EUR 776.4 |
Description: Clone your gene of interest into this AAV Expression Vector, then co-transfect along with AAV packaging vectors into a packaging host cell line such as 293AAV. |
pSMPUW-Neo Lentiviral Expression Vector |
|||
VPK-213 | Cell Biolabs | 10 µg | EUR 748.8 |
Description: Clone your gene of interest into this Lentiviral Expression Vector, then co-transfect along with lentiviral packaging vectors into a packaging cell line such as 293LTV. This expression vector is compatible with any 2nd or 3rd generation lentiviral packaging system, but due to its design it is best matched with our ViraSafe packaging vectors to produce the highest viral titer. |
Claudin-6 CHO Cell Line (Low Expression) |
|||
78527-L | BPS Bioscience | 2 vials | EUR 7150 |
Description: Recombinant clonal CHO cell line stably expressing full-length human claudin-6 (CLDN6 gene accession number NM_021195.5). Surface expression of claudin 6 was confirmed by flow cytometry. The stable clonal cell line was selected for high, medium, or low levels of claudin-6 expression compared to the parental CHO-K1 cell line. |
RAPAd® RSV Adenoviral Expression System |
|||
VPK-251 | Cell Biolabs | 1 kit | EUR 1243.2 |
Description: Making an adenovirus with traditional recombinant methods takes 2-3 months and requires tedious plaque recombination. More recent technologies have shortened this time somewhat, but still produce relatively high amounts of wild type (replication-competent) plaques, levels of which increase with serial amplification. The RAPAd® Adenoviral Expression Systems produce recombinant adenovirus with substantially reduced wild-type virus, while considerably shortening the production time to 2-3 weeks. Serial amplification of adenovirus produced using the RAPAd® system does not significantly increase replication-competent adenovirus levels. The system uses a backbone vector from which the 5' ITR, packaging signal and E1 sequences have been removed. |
RAPAd® CMV Adenoviral Expression System |
|||
VPK-252 | Cell Biolabs | 1 kit | EUR 1243.2 |
Description: Making an adenovirus with traditional recombinant methods takes 2-3 months and requires tedious plaque recombination. More recent technologies have shortened this time somewhat, but still produce relatively high amounts of wild type (replication-competent) plaques, levels of which increase with serial amplification. The RAPAd® Adenoviral Expression Systems produce recombinant adenovirus with substantially reduced wild-type virus, while considerably shortening the production time to 2-3 weeks. Serial amplification of adenovirus produced using the RAPAd® system does not significantly increase replication-competent adenovirus levels. The system uses a backbone vector from which the 5' ITR, packaging signal and E1 sequences have been removed. |
pSMPUW-Puro Lentiviral Expression Vector |
|||
VPK-212 | Cell Biolabs | 10 µg | EUR 748.8 |
Description: Clone your gene of interest into this Lentiviral Expression Vector, then co-transfect along with lentiviral packaging vectors into a packaging cell line such as 293LTV. This expression vector is compatible with any 2nd or 3rd generation lentiviral packaging system, but due to its design it is best matched with our ViraSafe packaging vectors to produce the highest viral titer. |
Claudin-6 CHO Cell Line (High Expression) |
|||
78527-H | BPS Bioscience | 2 vials | EUR 7150 |
Description: Recombinant clonal CHO cell line stably expressing full-length human claudin-6 (CLDN6 gene accession number NM_021195.5). Surface expression of claudin 6 was confirmed by flow cytometry. The stable clonal cell line was selected for high, medium, or low levels of claudin-6 expression compared to the parental CHO-K1 cell line. |
AAV-DJ/8 Helper Free Expression System |
|||
VPK-410-DJ-8 | Cell Biolabs | 1 kit | EUR 1486.8 |
Description: The AAV Helper Free System produces recombinant AAV containing your gene of interest without the need to use a helper adenovirus. The adenoviral genes required for proper AAV packaging are provided in the pHelper plasmid (E2A, E4 and VA RNA) or in the 293 packaging cells (E1). AAV Helper Free Complete Expression Systems are available for native serotypes 1 through 6, as well as the novel AAV-DJ and AAV-DJ/8. The AAV-DJ system provides a hybrid capsid created by DNA shuffling technology combining 8 different native serotypes: AAV-2, AAV-4, AAV-5, AAV-8, AAV-9, avian AAV, bovine AAV, and caprine AAV. The result is a highly infectious vector that can transduce a wide variety of cells and tissues at significantly higher rates than AAV-2. AAV-DJ/8 was created by making a point mutation in the heparin binding domain of AAV-DJ. Recombinant AAV produced from the AAV-DJ/8 system closely resembles AAV-8 and AAV-9 in its ability to infect heart and brain tissues. |
Myelin Expression Factor 2 (MYEF2) Antibody |
|||
abx235464-100ug | Abbexa | 100 ug | EUR 577.2 |
Myelin Expression Factor 2 (MYEF2) Antibody |
|||
20-abx109333 | Abbexa |
|
|
Myelin Expression Factor 2 (MYEF2) Antibody |
|||
20-abx113906 | Abbexa |
|
|
Expression Negative Control Lentivirus (G418) |
|||
79902-G | BPS Bioscience | 500 µl x 2 | EUR 795 |
Description: The Expression Negative Control Lentivirus are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to be transduced into almost all types of mammalian cells, including primary and non-dividing cells. The controls package the same virus particles as the target expression virus, but they do not express a specific protein under the CMV promoter. _x000D_The Expression Negative Control Lentivirus (G418) expresses the gene for aminoglycoside 3' phosphotransferase, which confers resistance to kanamycin, neomycin, and geneticin (G418)._x000D_The Expression Negative Control Lentivirus (Hygromycin) expresses the gene for hygromycin B phosphotransferase, which confers resistance to Hygromycin._x000D_The Expression Negative Control Lentivirus (Puromycin) expresses the gene for puromycin N-acetyl-transferase, which confers resistance to puromycin._x000D_ _x000D_ |
pGreenPuro shRNA expression lentivector (CMV) |
|||
SI505A-1 | SBI | 10 ug | EUR 594 |
pGreenPuro shRNA expression lentivector (EF1) |
|||
SI506A-1 | SBI | 10 ug | EUR 594 |
pSMPUW-Hygro Lentiviral Expression Vector |
|||
VPK-214 | Cell Biolabs | 10 µg | EUR 748.8 |
Description: Clone your gene of interest into this Lentiviral Expression Vector, then co-transfect along with lentiviral packaging vectors into a packaging cell line such as 293LTV. This expression vector is compatible with any 2nd or 3rd generation lentiviral packaging system, but due to its design it is best matched with our ViraSafe packaging vectors to produce the highest viral titer. |
Baculovirus expression vector pAc-g-CH3 |
|||
30R-AB001 | Fitzgerald | 5 ug | EUR 739.2 |
Description: Baculovirus cassette vector pAc-l-CH3 for the expression of human, humanized or chimeric IgG(lambda) in insect cells and secretion of assembled antibodies into the supernatant. |
Genorise® Chicken CCL7 Expression Plasmid |
|||
GR148007 | Genorise Scientific | 10 µg | EUR 219 |
RAPAd® miRNA Adenoviral Expression System |
|||
VPK-253 | Cell Biolabs | 1 kit | EUR 1243.2 |
Description: Making an adenovirus with traditional recombinant methods takes 2-3 months and requires tedious plaque recombination. More recent technologies have shortened this time somewhat, but still produce relatively high amounts of wild type (replication-competent) plaques, levels of which increase with serial amplification. The RAPAd® Adenoviral Expression Systems produce recombinant adenovirus with substantially reduced wild-type virus, while considerably shortening the production time to 2-3 weeks. Serial amplification of adenovirus produced using the RAPAd® system does not significantly increase replication-competent adenovirus levels. The system uses a backbone vector from which the 5' ITR, packaging signal and E1 sequences have been removed. |
Claudin-6 CHO Cell Line (Medium Expression) |
|||
78527-M | BPS Bioscience | 2 vials | EUR 7150 |
Description: Recombinant clonal CHO cell line stably expressing full-length human claudin-6 (CLDN6 gene accession number NM_021195.5). Surface expression of claudin 6 was confirmed by flow cytometry. The stable clonal cell line was selected for high, medium, or low levels of claudin-6 expression compared to the parental CHO-K1 cell line. |
scAAV-DJ/8 Helper Free Expression System |
|||
VPK-430-DJ-8 | Cell Biolabs | 1 kit | EUR 1486.8 |
Description: The AAV Helper Free System produces recombinant AAV containing your gene of interest without the need to use a helper adenovirus. The adenoviral genes required for proper AAV packaging are provided in the pHelper plasmid (E2A, E4 and VA RNA) or in the 293 packaging cells (E1). AAV Helper Free Complete Expression Systems are available for native serotypes 1 through 6, as well as the novel AAV-DJ and AAV-DJ/8. The AAV-DJ system provides a hybrid capsid created by DNA shuffling technology combining 8 different native serotypes: AAV-2, AAV-4, AAV-5, AAV-8, AAV-9, avian AAV, bovine AAV, and caprine AAV. The result is a highly infectious vector that can transduce a wide variety of cells and tissues at significantly higher rates than AAV-2. AAV-DJ/8 was created by making a point mutation in the heparin binding domain of AAV-DJ. Recombinant AAV produced from the AAV-DJ/8 system closely resembles AAV-8 and AAV-9 in its ability to infect heart and brain tissues. |
pC001 - huLshC2C2- MBP for bacterial expression |
|||
PVT10645 | Lifescience Market | 2 ug | EUR 361.2 |
Exoenzyme C3 (Rho Inhibitor) Expression Vector |
|||
STA-460 | Cell Biolabs | 1 kit | EUR 860.4 |
Description: This mammalian expression vector codes for Exoenzyme C3, a Rho inhibitor. |
Protein Limb Expression 1 (LIX1) Antibody (HRP) |
|||
20-abx308975 | Abbexa |
|
|
LEXSYcon2.1 Expression Kit M-EGE-1310ble ** shipped on blue ice/Dry Ice (two separate boxes) - must be shipped overnight |
|||
M-EGE-1310ble | MiTeGen | 1 Kit | EUR 1682 |
Description: LEXSYcon2.1 Expression Kit M-EGE-1310ble ** shipped on blue ice/Dry Ice (two separate boxes) - must be shipped overnight |
LEXSYcon2.1 Expression Kit M-EGE-1310bsd ** shipped on blue ice/Dry Ice (two separate boxes) - must be shipped overnight |
|||
M-EGE-1310bsd | MiTeGen | 1 Kit | EUR 1682 |
Description: LEXSYcon2.1 Expression Kit M-EGE-1310bsd ** shipped on blue ice/Dry Ice (two separate boxes) - must be shipped overnight |
LEXSYcon2.1 Expression Kit M-EGE-1310hyg ** shipped on blue ice/Dry Ice (two separate boxes) - must be shipped overnight |
|||
M-EGE-1310hyg | MiTeGen | 1 Kit | EUR 1682 |
Description: LEXSYcon2.1 Expression Kit M-EGE-1310hyg ** shipped on blue ice/Dry Ice (two separate boxes) - must be shipped overnight |
LEXSYcon2.1 Expression Kit M-EGE-1310neo ** shipped on blue ice/Dry Ice (two separate boxes) - must be shipped overnight |
|||
M-EGE-1310neo | MiTeGen | 1 Kit | EUR 1682 |
Description: LEXSYcon2.1 Expression Kit M-EGE-1310neo ** shipped on blue ice/Dry Ice (two separate boxes) - must be shipped overnight |
LEXSYcon2.1 Expression Kit M-EGE-1310pac ** shipped on blue ice/Dry Ice (two separate boxes) - must be shipped overnight |
|||
M-EGE-1310pac | MiTeGen | 1 Kit | EUR 1682 |
Description: LEXSYcon2.1 Expression Kit M-EGE-1310pac ** shipped on blue ice/Dry Ice (two separate boxes) - must be shipped overnight |
LEXSYcon2.1 Expression Kit M-EGE-1310sat ** shipped on blue ice/Dry Ice (two separate boxes) - must be shipped overnight |
|||
M-EGE-1310sat | MiTeGen | 1 Kit | EUR 1682 |
Description: LEXSYcon2.1 Expression Kit M-EGE-1310sat ** shipped on blue ice/Dry Ice (two separate boxes) - must be shipped overnight |
Cre Recombinase Expression Plasmid (pCMV-CRE) |
|||
CRE100A-1 | SBI | 10 µg | EUR 412 |
×
Nonetheless, a rising physique of proof highlights the crucial function of TRPM7 in autoimmune ailments, together with rheumatoid arthritis, a number of sclerosis, and diabetes. Herein we current; a) a evaluation of the channel kinase properties of TRPM7 and its pharmacological properties, b) talk about the function of TRPM7 in immune cells (neutrophils, macrophages, lymphocytes, and mast cells) and its upstream immunoreactive substances, and c) spotlight TRPM7 as a possible therapeutic goal for autoimmune ailments.
Tags: adam17 antibody anti bsa antibodies anti gfp beads anti goat hrp antibodies for flow cytometry antibody purification axin2 antibody brd4 antibody collagen 1 antibody eif2a antibody exosome isolation protocol flag tag antibody galc antibody gfp antibody gst resin hotstart taq ikk gamma mfn1 antibody mouse msc myeloperoxidase elisa nse antibody pdgfa antibody pecy5 prmt5 antibody rat igg2a isotype control recombinant human il 2 ros dye sds buffers serotonin antibody smi32 antibody streptavidin horseradish peroxidase conjugate transfection reagents western blot transfer buffer western blot transfer buffer recipe western blot washing buffer western blotting loading controls